{"schema_version":"secwatch.filing_event.v1","accession":"0001214659-26-008772","form_type":"8-K","ticker":"ALZN","cik":"0001677077","company_name":"Alzamend Neuro, Inc.","filed_at":"2026-07-21T20:30:22+00:00","discovered_at":"2026-07-21T20:31:04.271242+00:00","generated_at":"2026-07-21T20:31:37.244272+00:00","sec_items":["8.01","9.01"],"event_type":"leadership","sentiment":"negative","materiality_score":0.5,"calibrated_materiality_score":0.5,"confidence":"high","headline":"Alzamend Neuro announces death of director Lynne Fahey McGrath on July 20, 2026","bullets":["Dr. Lynne Fahey McGrath, a director of Alzamend Neuro, passed away on July 20, 2026.","She served on the Board since the company's IPO in June 2021.","Chairman William B. Horne expressed condolences and highlighted her contributions and insights."],"urls":{"canonical":"https://secwatch.observer/filing/0001214659-26-008772","json":"https://secwatch.observer/filing/0001214659-26-008772.json","markdown":"https://secwatch.observer/filing/0001214659-26-008772.md","text":"https://secwatch.observer/filing/0001214659-26-008772.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1677077/000121465926008772/0001214659-26-008772-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1677077/000121465926008772/p7202618k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-07-21T20:31:37.244272+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}